CBX1 and transient ischemic attack: AlphaLISA enabled us to quantitate the precise levels of these serum antibodies, and the results illustrated that the antibody levels of anti-MMP1, anti-CBX1, and anti-CBX5 were significantly elevated not only in aCI but also in TIA patients compared with HDs (Figure 3).